Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Non Interventional Study of VPRIV® (Velaglucerase Alfa) Home Therapy in Patients With Gaucher's Disease

NCT01356537 is registered in ClinicalTrials.gov with Shire as lead sponsor.

NCT NCT01356537
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01356537 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Non Interventional Study of VPRIV® (Velaglucerase Alfa) Home Therapy in Patients With Gaucher's Disease
Lead sponsor
Shire
Phase
Observational
Overall status
Completed
Start date
May 20, 2011
Completion date
September 30, 2017
Enrollment
34 (actual)
Sites
11

Conditions

As the registry lists them; a condition with its own page is linked.

gaucher disease